Anna-Maria Fontrier is a Senior Researcher at the Medical Technology Research Group (MTRG), LSE Health. She has been involved in consultancy projects for both, private and public sector and in the research and coordination of IMPACT HTA European Union’s Horizon 2020 research and innovation programme. Past work experience includes junior roles at the Health Reform Support Program for Greece and Novartis Hellas.
Anna-Maria holds an MSc in International Health Policy from LSE and a BSc in Chemistry and Business Administration from Aston University. She is currently a PhD candidate at LSE.